Medicenna Therapeutics Corp. (MDNA:CA) Discusses New Scientific Knowledge From ABILITY-1 Research Evaluating MDNA11 in Most cancers Immunotherapy Transcript
Operator Welcome to Medicenna Therapeutics KOL Webinar. As a reminder, this convention name is being recorded. When you've got any...